Circadian rhythm of granulocyte-macrophage colony-stimulating factor in normal subjects and neutropenic hospitalised patients
Granulocyte-macrophage colony-stimulating factor (GM-CSF), one of the haemopoietic growth factors, has rarely been detected in human serum. It has, therefore, been suggested that a paracrine model can explain its behaviour where the substance is produced and acts locally. An alternative explanation might be due to blood sampling time with GM-CSF concentrations undetectable at the nadir of secretion.
We hypothesised that endogenous production of GM-CSF in humans is subject to diurnal rhythm.
Blood samples were obtained from 17 healthy individuals and 17 neutropenic hospitalised patients with haematological malignancies on myelosuppressive therapy at 6, 12, 18 and 24 hours. In the neutropenic patients, samples were collected at the nadir of the neutrophil count (ANC <0.2 × 109/L). Serum was assayed for GM-CSF levels using an enzyme-linked immunosorbent assay method.
There were significant differences in the mean levels of GM-CSF within the two groups (P<0.001). In normal subjects, peak GM-CSF levels were reached at six hours (mean = 10.1 pg/ml). Peak levels were reached in hospitalised neutropenic patients at 18 hours (mean = 13.7 pg/ml). The difference between the peak GM-CSF levels in the two groups was not significant (P=0.11). On factorial design analysis, there was a significant interaction between the time of blood collection and the subject groups (P<0.001).
Our data are consistent with a diurnal secretion pattern for GM-CSF in both normal and neutropenic patients. As this finding might have practical implications, including timing of administration of GM-CSF in neutropenic patients, further studies are suggested.
KeywordsCircadian Rhythm Neutropenic Patient Endogenous Production Haemopoietic Growth Factor Factorial Design Analysis
Unable to display preview. Download preview PDF.
- 4.Whetton AD, Dexter TM: Myeloid haemopoietic growth factors.Biochemien et Biophysica Acta 1989; 989(2): 111–132.Google Scholar
- 5.Fibbe WE, Van Damme J, Billiau A, Goselink HM, Voogt PJ, Van Eeden G, Ralph P, Altrock BVV, Falkenburg JH: Interleukin-l induces human stromal cells in long-term culture to produce granulocyte colony -stimulating factor and macrophage colony-stimulating factor.Blood 1988; 71(2): 430–5.PubMedGoogle Scholar
- 8.Stanley E, Lieschke GJ, Grail D, Metcalf D, Hudgson G, Gall JAM, Maher DW, Cebon J, Sinickas V, Dunn AR: Granulocyte-macrophage colony-stimulating factor deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.Proc Nat Acad Sci USA 1994; 91 (12): 5592–6.CrossRefPubMedGoogle Scholar
- 9.Layton JE, Cebon JS, Morstyn G: Cytokine responses to febrile neutropenia.Exp Hematol. 1991; 19: 506 (abstr).Google Scholar
- 15.Kennon BR: A study of the white blood cells picture in six young men.Am J Physiol 1937; 118: 690–9.Google Scholar
- 17.Ruef C, Coleman DL: Granulocyte-macrophage colony-stimulating factor: pleotropic cytokine with potential clinical usefulness.Rev of Inf Dis 1990; 12(1): 41–62.Google Scholar